ABBV: This Top Biotech Just Went On A Buying Spree
January 25, 2024 at 07:00 AM EST
AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
